Advances in Early Diagnosis

This article shows how some surprising technologies are improving the early detection of several conditions. Nutromics continuously monitors the delivery of an antibiotic used to treat sepsis. Eye-tracking from Tobii is used by several of its clients to detect certain kinds of autism as early as twelve months of age. And Cordio Medical is detecting oncoming congestive heart failure (CHF) three weeks in advance of an incident. Minimally Invasive Monitoring Provides Real-Time Measurements Although doctors learn what people have in their bodies most often through blood tests, technologies developed over the past few decades can find a lot of information without inserting a large needle and removing blood from veins. According to Dr. Agim Beshiri, chief medical officer of Nutromics, a lot of molecules are accessible near the skin’s surface through interstitial fluid (ISF) and even sweat. Nutromics takes advantage of this with an innovative, minimally invasive, methodology to check for various conditions. First, they research the molecule that they’re trying to detect. They then create a synthetic DNA strand that can latch onto it, in the same manner that pharma companies use mRNA or DNA to develop vaccines and deliver drugs into the body. Fig 1. Nutromics patch Nutromics developed a “lab-on-a-patch,” about two centimeters or one inch long (Figure 1), that contains a few tiny needles. These needles penetrate only one millimeter into the patient’s skin...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: AI/Machine Learning Clinical Health IT Company Healthcare IT Telemedicine and Remote Monitoring ADOS Agim Beshiri AI Diagnosis Autism CHF Cordio Medical Eye Tracking Eye Tracking Sensors Healthcare Sensors HearO Karen Pierce Source Type: blogs